-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Evolent Health, Raises Price Target to $7

Benzinga·06/12/2026 14:11:18
Listen to the news
Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $6 to $7.